If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yong Teng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Neoplasm Metastasis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Genes Medicine & Life Sciences
Zebrafish Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
ADP-Ribosylation Factor 1 Medicine & Life Sciences
Iridovirus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

  • 1124 Citations
  • 20 h-Index
  • 54 Article
  • 8 Review article
  • 2 Chapter

ATAD3A on the path to cancer

Teng, Y., Lang, L. & Shay, C., Jan 1 2019, Advances in Experimental Medicine and Biology. Springer New York LLC, p. 259-269 11 p. (Advances in Experimental Medicine and Biology; vol. 1134).

Research output: Chapter in Book/Report/Conference proceedingChapter

Adenosine Triphosphatases
13 Citations (Scopus)

Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3–p38 MAPK signalling

Wen, S., Hou, Y., Fu, L., Xi, L., Yang, D., Zhao, M., Qin, Y., Sun, K., Teng, Y. & Liu, M., Feb 1 2019, In : Cancer Letters. 442, p. 320-332 13 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasm Metastasis
p38 Mitogen-Activated Protein Kinases
3 Citations (Scopus)

FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma

Gao, L., Lang, L., Zhao, X., Shay, C., Shull, A. Y. & Teng, Y., Mar 28 2019, In : Oncogene. 38, 13, p. 2394-2404 11 p.

Research output: Contribution to journalArticle

Fibroblast Growth Factor Receptors
Autocrine Communication
Fibroblast Growth Factors
Gene Amplification
1 Citation (Scopus)
Open Access
ADP-Ribosylation Factor 1
Histone Deacetylase Inhibitors
Epidermal Growth Factor Receptor
2 Citations (Scopus)

Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression

Lang, L., Shull, A. Y. & Teng, Y., Jan 1 2019, In : Current cancer drug targets. 19, 1, p. 17-25 9 p.

Research output: Contribution to journalArticle

Fibroblast Growth Factors
Cell Proliferation
Neoplasm Metastasis